1994년 4월 1일부터 8월 31일까지 영남대학 의과대학 부속병원 신경과에 내원한 환자중에서 뇌척수액 검사를 시행한 환자 50례를 대상으로 혈청과 뇌척수액의 HBV 검출률과 HBV의 감염과 신경계질환의 관련성을 알아보기 위해 혈청과 뇌척수액에서 HBV 표식자를 검출하여 다음과 같은 결과를 얻었다. 혈청 HBV 표식자 검출로 HBsAg 양성률은 12.0%, HBV 감염률은 74.0% 이었으며, HBV에 의한 감염을 표식자 검출 양상에 따라 A군은 12.0%, B군은 62.0%이었고, C군은 26.0%이었다. 뇌척수액 HBV 표식자 검출로 HBsAg 양성률은 6.0%, HBV 감염률은 36.0%이었으며, A군은 100.0%, B군은 38.7%이었고, C군에서는 검출되지 않았다. 신경계 질환별로 분류하면 VDA군은 26명, NVAD군은 24명이었다. 혈청 HBV 감염률은 VAD군은 88.5%, NVAD군은 58.3%로 두 군간의 유의한 상관관계가 있었다(p<0.05). 뇌척수액의 HBV 표식자 검출은 VAD군 53.8%, NVAD군 16.7% 검출되었다 (p<0.05). VAD군에서 혈청 HBV 감염이 있는 경우 60.9%, NVAD군은 28.6%에서 뇌척수액 HBV 표식자가 검출되었으며, 대상환자의 수가 적어 두 군간의 통계학적 유의수준은 없었다. 이상의 결과로 보아 혈청 HBV 표식자가 검출되는 경우 일부 뇌척수액에서 HBV 표식자가 검출되며, 혈청 HBsAg 양성일때 검출률이 증가하고, 바이러스와 연관된 신경계 질환에서 혈청과 뇌척수액의 HBV의 검출률이 높았다.
We investigated HBV markers in serum and cerebrospinal fluid of 50 subjects with neurologic disorders or other disorders, who visited Dept. of neurology, college of medicine, Yeungnam University, from April-1 to August-31 1994 and were performed cerebrospinal fluid analysis to investigate the detection rate of HBV markers in cerebrospinal fluid and the possibility of neurologic disorders associated with HBV infection. The results were as follows. The positivity of HBsAg and HBV prevalence rate in serum were 6(12.0%) and 37(74.0%). The number of patient with HBsAg, only anti-HBV and no markers were 6(12.0%), 31(62.0%) and 13(26.0%), respectively. The positivity of HBsAg and HBV prevalence rate in cerebrospinal fluid were 3(6%) and 18(36.0%). The number of patient with HBsAg, only anti-HBV and no markers were 6(100.0%), 12(38.7%) and 0(0.0%) respectively. The number of patient with virus associated diseases(VAD) and non virus associated diseases(NVAD) were 26(52%) and 24(48%). The HBV prevalence rate in serum of VAD and NVAD groups were 88.5% and 58.3% (p<0.05). The HBV prevalence rate in CSF of VAD and NVAD groups were 53.8% and 16.7%(P<0.05). The HBV prevalence rate in serum and CSF of VAD and NVAD groups were 60.9% and 28.6%. Aa a conclusion, the HBV markers in the CSF were partially detected at the presence of the HBV markers in serum. The prevalance rate of HBV in the CSF was increased at the HBsAg positive in the serum and the serum and the CSF was significantly increased at the VAD group than the NVAD group.
